The practice of Rheumatology and Clinical Immunology has made big strides in the last decade. The availability of immune modifiers, e.g. anti-cytokine agents, has changed the therapeutic landscape of arthritis treatment. What is refractory arthritis previously had now become controllable disease.
This article is available only as a PDF. Please click on “Download PDF” to view the full article.
